EGFR and prostate carcinoma: Using the prostate cancer LNCaP cell line, which is also endowed with AR-T877A mutated variant, we observe that 50 and 100 μM BPA causes cell cycle arrest which is mediated by a non-transcriptional mechanism involving EGFR, ERK, AR, and ERβ.